DELTEC ASSET MANAGEMENT LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
DELTEC ASSET MANAGEMENT LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2020$2,654,000
+64.6%
30,420
+69.0%
0.48%
+40.9%
Q2 2020$1,612,00018,0000.34%
Other shareholders
HAEMONETICS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders